<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-80426</identifier>
<setSpec>0210-5020</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Caring for perilesional skin or skin having a lesion risk</dc:title>
<dc:description xml:lang="en">In order to increase the clinical and scientific evidence of the Hyperoxygenated Fatty Acids (HFA) in emulsion preparation for skin care, this study considers to evaluate prospectively how it influences in the state of the periwound skin (when there are active lesions) or in which it presents a high risk of lesion production(AU)</dc:description>
<dc:creator>Javares Curto, T</dc:creator>
<dc:creator>Barahona, M</dc:creator>
<dc:creator>Verdú Soriano, J</dc:creator>
<dc:creator>Segovia Gómez, T</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Para aumentar la evidencia clínica y científica de los AGHO en emulsión en el cuidado de la piel, se plantea este estudio con el objetivo de evaluar prospectivamente cómo influye Mepentol® Leche en el estado de la piel perilesional (cuando hay lesiones instauradas) o en aquella que presenta un elevado riesgo de lesión(AU)</dc:description>
<dc:source>Rev Enferm;30(10): 683-688, oct. 2007. ilus</dc:source>
<dc:identifier>ibc-80426</dc:identifier>
<dc:title xml:lang="es">Cuidados en piel perilesional o con riesgo de lesión</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d13264^s22054</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d5331^s22073</dc:subject>
<dc:subject>^d4732^s22073</dc:subject>
<dc:subject>^d31040^s22045</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:type>article</dc:type>
<dc:date>200710</dc:date>
</metadata>
</record>
</ibecs-document>
